---
title: "Palmitoyl Tripeptide-1"
canonical_url: https://peptidelibrary.app/library/palmitoyl-tripeptide-1
description: "The GHK tripeptide supplied with a palmitic acid chain attached to improve penetration through the outer skin barrier, and without the bound copper of GHK-Cu. It is used topically as a matrikine, a peptide fragment that signals matrix turnover to dermal fibroblasts, and is most often formulated alongside palmitoyl tetrapeptide-7. Regulated as a cosmetic ingredient rather than a drug, and not FDA-approved for any therapeutic use."
updated: 2026-11-07
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# Palmitoyl Tripeptide-1

Palmitoyl Tripeptide-1 (also called Pal-GHK or Biopeptide CL) is a cosmetic copper-free GHK analog in the Copper Peptide class. Palmitoyl tripeptide-1 delivers the GHK sequence with a sixteen-carbon palmitic acid chain attached to the N-terminus. The lipid tail greatly increases lipophilicity, which is intended to improve partitioning into the stratum corneum, the main barrier to topical peptide delivery.

The GHK tripeptide supplied with a palmitic acid chain attached to improve penetration through the outer skin barrier, and without the bound copper of GHK-Cu. It is used topically as a matrikine, a peptide fragment that signals matrix turnover to dermal fibroblasts, and is most often formulated alongside palmitoyl tetrapeptide-7. Regulated as a cosmetic ingredient rather than a drug, and not FDA-approved for any therapeutic use.

Also known as: Pal-GHK, Biopeptide CL, Part of Matrixyl 3000.

Categories: Cosmetic, Experimental.

## Classification

- Type: Cosmetic copper-free GHK analog
- Mechanism class: Copper Peptide
- Development stage: Research only
- Regulatory class: Research compound, not FDA-approved

## Mechanism

Palmitoyl tripeptide-1 delivers the GHK sequence with a sixteen-carbon palmitic acid chain attached to the N-terminus. The lipid tail greatly increases lipophilicity, which is intended to improve partitioning into the stratum corneum, the main barrier to topical peptide delivery. Unlike GHK-Cu it is supplied without bound copper. It is described as a matrikine — a peptide fragment that signals extracellular matrix turnover to dermal fibroblasts — and supplier studies report increased collagen and glycosaminoglycan synthesis in fibroblast assays. It is most often formulated alongside palmitoyl tetrapeptide-7, and most published data concerns those finished combinations rather than the isolated ingredient.

Targets: Dermal fibroblasts.

Origin: Synthetic palmitoyl-GHK.

## Properties

- Molecular formula: C30H54N6O5
- Molecular weight: ≈578.8 g/mol
- CAS number: 147732-56-7
- Half-life: Topical; systemic PK not established

## Evidence

- Evidence level: Insufficient Evidence
- Highest documented: Early or uncontrolled human studies
- Human trials: 2
- Controlled human trials: 0
- Preclinical sources: 1
- Latest source: 2026

No human dose is established for this compound.

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

### Studies

1. Yang F et al. Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream. Skin Res Technol. 2024. 2024. Human study (early or uncontrolled). Population: Adults using the eye cream (number not stated in the indexed abstract). Skin hydration +28.12%, elasticity +18.81% and ultrasound collagen measure +54.99% at 12 weeks; reported as well tolerated [Source](https://pubmed.ncbi.nlm.nih.gov/38932444/)
2. Trzaska AH et al. Permeation behaviour of cosmetic actives into the human stratum corneum. Int J Pharm. 2026. 2026. Human study (early or uncontrolled). Population: 3 healthy women. Both palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 were found through every layer of the stratum corneum, between the cells rather than inside them, at falling levels with depth [Source](https://pubmed.ncbi.nlm.nih.gov/42790608/)
3. Zang S et al. Mechanistic understanding and peptide ingredient screening for type III collagen via biological knowledge graph and molecular docking. Int J Cosmet Sci. 2026. 2026. Preclinical: in vitro (cells or tissue). Population: Human dermal fibroblasts and ex vivo skin. Palmitoyl tripeptide-1 was one of four peptides that raised type III collagen after UV exposure without detectable cytotoxicity; the combination had a larger effect than single peptides. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/42683869/)

## Safety

Side effects: Irritation.

Risks: Cosmetic only.

Human safety basis: No controlled human safety data

Key limitations: No established human dosage.; No controlled human trial results in the reviewed sources.; Not approved by the FDA for any use..

## Regulatory status

Palmitoyl Tripeptide-1 is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

- FDA status: Not Approved
- WADA status: Permitted
- Availability: OTC / Supplement

## Frequently asked questions

### What is Palmitoyl Tripeptide-1?

The GHK tripeptide supplied with a palmitic acid chain attached to improve penetration through the outer skin barrier, and without the bound copper of GHK-Cu. It is used topically as a matrikine, a peptide fragment that signals matrix turnover to dermal fibroblasts, and is most often formulated alongside palmitoyl tetrapeptide-7. Regulated as a cosmetic ingredient rather than a drug, and not FDA-approved for any therapeutic use.

### How does Palmitoyl Tripeptide-1 work?

Palmitoyl tripeptide-1 delivers the GHK sequence with a sixteen-carbon palmitic acid chain attached to the N-terminus. The lipid tail greatly increases lipophilicity, which is intended to improve partitioning into the stratum corneum, the main barrier to topical peptide delivery.

### Is Palmitoyl Tripeptide-1 FDA approved?

No. Palmitoyl Tripeptide-1 is not approved by the FDA for any indication and is categorised as otc / supplement. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

### What is the half-life of Palmitoyl Tripeptide-1?

Reported half-life for Palmitoyl Tripeptide-1 is Topical; systemic PK not established. Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

### Is Palmitoyl Tripeptide-1 banned in sport?

Palmitoyl Tripeptide-1 is recorded here as permitted in sport. Anti-doping status is revised annually, so athletes subject to testing should confirm against the current WADA Prohibited List before use.

### What peptides are similar to Palmitoyl Tripeptide-1?

Compounds most often compared with Palmitoyl Tripeptide-1 include GHK-Cu (Copper Peptide), AHK-Cu, Acetyl Hexapeptide-8 and Acetyl Octapeptide-3. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

## References

- [EGCG-Biotin-Pal-GHK composition modulates TGF-β and BMP pathways in scalp microenvironment for treating stress-induced alopecia — Eur J Pharmacol, 2026](https://pubmed.ncbi.nlm.nih.gov/42575238/)
- [Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective — Bioimpacts, 2025](https://pubmed.ncbi.nlm.nih.gov/39963574/)
- [Targeting Circadian Rhythm for the Regulation of Skin Collagen Metabolism — J Cosmet Dermatol, 2026](https://pubmed.ncbi.nlm.nih.gov/41527525/)
- [Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines — Biochem Biophys Res Commun, 2025](https://pubmed.ncbi.nlm.nih.gov/39632290/)
- [Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics — Anal Chim Acta, 2009](https://pubmed.ncbi.nlm.nih.gov/19393372/)
